Breaking News

Catalent Adds Cryogenic Capabilities at Philadelphia Facility

Bolsters clinical supply services at site to meet growing demand for cell and gene therapy development.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalent, a global provider of advanced delivery technologies, development, manufacturing, and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, has made an investment to expand capabilities at its clinical supply services facility in Philadelphia to support sponsors developing cell and gene therapies.   The investment has enabled part of the facility to be dedicated to the safe handling of cell and gene therapy samples, including the installa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters